Literature DB >> 12968793

Paranoid psychosis related to mefloquine antimalarial prophylaxis.

S J Fuller1, S Naraqi, G Gilessi.   

Abstract

Mefloquine is an important antimalarial drug for treatment and prophylaxis of chloroquine-resistant malaria. Its use has been associated with neuropsychiatric side-effects. We report a case of paranoid psychosis associated with mefloquine occurring in a remote part of Papua New Guinea. Adverse reactions and contraindications are discussed. This case underlines the importance of awareness of neuropsychiatric side-effects with mefloquine use and of taking a careful psychiatric history before prescribing mefloquine.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12968793

Source DB:  PubMed          Journal:  P N G Med J        ISSN: 0031-1480


  3 in total

1.  The risk of severe depression, psychosis or panic attacks with prophylactic antimalarials.

Authors:  Christoph R Meier; Karen Wilcock; Susan S Jick
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

2.  Prolonged Neuropsychiatric Symptoms in a Military Service Member Exposed to Mefloquine.

Authors:  Jeffrey Livezey; Thomas Oliver; Louis Cantilena
Journal:  Drug Saf Case Rep       Date:  2016-12

3.  Antimalarial drugs and the prevalence of mental and neurological manifestations: A systematic review and meta-analysis.

Authors:  Mary A Bitta; Symon M Kariuki; Clifford Mwita; Samson Gwer; Leah Mwai; Charles R J C Newton
Journal:  Wellcome Open Res       Date:  2017-06-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.